For: | Xiu P, Dong XF, Li XP, Li J. Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma. World J Gastroenterol 2015; 21(27): 8262-8270 [PMID: 26217078 DOI: 10.3748/wjg.v21.i27.8262] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i27/8262.htm |
Number | Citing Articles |
1 |
Na Li, Yanping Hu, Linguo Wu, Jianduo An. Clinicopathological correlations in 38 cases of gastroenteropancreatic high-grade neuroendocrine neoplasms. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1399079
|
2 |
Min Yao, Rong-Fei Fang, Qun Xie, Min Xu, Wen-Li Sai, Deng-Fu Yao. Early monitoring values of oncogenic signalling molecules for hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(6): 2350-2361 doi: 10.4251/wjgo.v16.i6.2350
|
3 |
Chengyun Yan, Jiwei Gu, Hongying Jing, Jinghua Taishi, Robert J. Lee. Tat-Tagged and Folate-Modified N-Succinyl-chitosan (Tat-Suc-FA) Self-assembly Nanoparticle for Therapeutic Delivery OGX-011 to A549 Cells. Molecular Pharmaceutics 2017; 14(6): 1898 doi: 10.1021/acs.molpharmaceut.6b01167
|
4 |
Yujing Zhang, Yiyuan Zhang, Yuanyuan Xiao, Caigao Zhong, Fang Xiao. Expression of Clusterin suppresses Cr(VI)-induced premature senescence through activation of PI3K/AKT pathway. Ecotoxicology and Environmental Safety 2019; 183: 109465 doi: 10.1016/j.ecoenv.2019.109465
|
5 |
Basem M. Abdallah, Abdullah M. Alzahrani, Moustapha Kassem. Secreted Clusterin protein inhibits osteoblast differentiation of bone marrow mesenchymal stem cells by suppressing ERK1/2 signaling pathway. Bone 2018; 110: 221 doi: 10.1016/j.bone.2018.02.018
|
6 |
Virginia Veronica Visconti, Chiara Greggi, Ida Cariati, Beatrice Gasperini, Ambra Mastrogregori, Annalisa Botta, Umberto Tarantino. Deregulated Clusterin as a Marker of Bone Fragility: New Insights into the Pathophysiology of Osteoporosis. Genes 2022; 13(4): 652 doi: 10.3390/genes13040652
|
7 |
Min Yao, Wenli Sai, Wenjie Zheng, Li Wang, Zhizhen Dong, Dengfu Yao. Secretory Clusterin as a Novel Molecular-targeted Therapy for Inhibiting Hepatocellular Carcinoma Growth. Current Medicinal Chemistry 2020; 27(20): 3290 doi: 10.2174/0929867326666190624161158
|
8 |
Faryal Mehwish Awan, Anam Naz, Ayesha Obaid, Aqsa Ikram, Amjad Ali, Jamil Ahmad, Abdul Khaliq Naveed, Hussnain Ahmed Janjua. MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11943-1
|
9 |
Suguru Mitsufuji, Yoshifumi Iwagami, Shogo Kobayashi, Kazuki Sasaki, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Tadafumi Asaoka, Takehiro Noda, Kunihito Gotoh, Hidenori Takahashi, Masahiro Tanemura, Yuichiro Doki, Hidetoshi Eguchi. Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer. Annals of Surgical Oncology 2022; 29(8): 4937 doi: 10.1245/s10434-022-11668-0
|
10 |
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Dengfu Yao, Zhizheng Dong. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.71007
|
11 |
Shu-Rong Xiao, Gui-Dan Xu, Wu-Jun Wei, Bin Peng, Yi-Bin Deng. Antiviral effects of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice. World Journal of Clinical Cases 2018; 6(8): 183-191 doi: 10.12998/wjcc.v6.i8.183
Abstract(1087) |
Core Tip(896) |
Full Article(HTML)(3220)
|
Full Article (PDF)-2160K(395)
|
Full Article (Word)-10783K(347)
|
Audio-1152K(10)
|
Peer-Review Report-180K(201)
|
Answering Reviewers-290K(213)
|
Full Article (PDF)-2230K(28)
|
Full Article (XML)-71K(26)
|
Times Cited (1)
|
Total Visits (13221)
|
Open
|
12 |
Prithi Raguraman, Akilandeswari Ashwini Balachandran, Suxiang Chen, Sarah D. Diermeier, Rakesh N. Veedu. Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation. Cancers 2021; 13(21): 5555 doi: 10.3390/cancers13215555
|
13 |
Malgorzata Kucinska, Hanna Piotrowska-Kempisty, Natalia Lisiak, Mariusz Kaczmarek, Hanna Dams-Kozlowska, Walter H. Granig, Martina Höferl, Walter Jäger, Martin Zehl, Marek Murias, Thomas Erker. Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells. Toxicology in Vitro 2016; 37: 148 doi: 10.1016/j.tiv.2016.09.017
|
14 |
Zhe Wang, Kun Zhao, Thilo Hackert, Margot Zöller. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression. Frontiers in Cell and Developmental Biology 2018; 6 doi: 10.3389/fcell.2018.00097
|
15 |
Jun Won PARK, Ki Taek NAM, Jae Hoon SHIN, Il Yong KIM, Kyung Mi CHOI, Kyung-Jin ROH, Seung Hyun OH, Young-Min YUN, Jun-Gyo SUH, Yang-Seok OH, Yeo Sung YOON, Je Kyung SEONG. Clusterin is highly expressed in tubular complexes during spontaneous pancreatitis of spontaneous hypertensive rats. Journal of Veterinary Medical Science 2018; 80(10): 1553 doi: 10.1292/jvms.18-0205
|
16 |
Abdullah Hoter, Hassan Y. Naim. Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities. Cancers 2019; 11(9): 1389 doi: 10.3390/cancers11091389
|
17 |
Jingtao Zhong, Xiaoming Yu, Xiaofeng Dong, Hong Lu, Wuyuan Zhou, Lei Li, Zhongchao Li, Pengfei Sun, Xuetao Shi. Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3463
|
18 |
Thomas W. Czeczok, Kristen M. Stashek, Jessica E. Maxwell, Thomas M. O’Dorisio, James R. Howe, Jason L. Hornick, Andrew M. Bellizzi. Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin. Applied Immunohistochemistry & Molecular Morphology 2018; 26(2): 94 doi: 10.1097/PAI.0000000000000563
|
19 |
Mariana Ferreira Cardoso, Mariana Verdelho Machado. The Changing Face of Hepatitis Delta Virus Associated Hepatocellular Carcinoma. Cancers 2024; 16(22): 3723 doi: 10.3390/cancers16223723
|